2,417
Views
1
CrossRef citations to date
0
Altmetric
Research Papers

Meet and eat, an interdisciplinary group intervention for patients with myotonic dystrophy about healthy nutrition, meal preparation, and consumption: a feasibility study

, , , , , & show all
Pages 1561-1568 | Received 03 Nov 2017, Accepted 21 Sep 2018, Published online: 20 Nov 2018

References

  • Harper P. Myotonic dystrophy: a multisystemic disorder. In: Harper P, Van Engelen B, Eymard B, Wilcox D, editors. Myotonic Dystrophy: present management, future therapy. Oxford: Oxford University Press; 2004. p. 3–13.
  • Antonini G, Soscia F, Giubilei F, et al. Health-related quality of life in myotonic dystrophy type 1 and its relationship with cognitive and emotional functioning. J Rehabil Med. 2006;38:181–185.
  • Gallais B, Gagnon C, Mathieu J, et al. Cognitive decline over time in adults with myotonic dystrophy type 1: a 9-year longitudinal study. Neuromuscul Disord. 2017;27:61–72.
  • Norwood FL, Harling C, Chinnery PF, et al. Prevalence of genetic muscle disease in Northern England: in-depth analysis of a muscle clinic population. Brain. 2009;132:3175–3186.
  • Motlagh B, MacDonald JR, Tarnopolsky MA. Nutritional inadequacy in adults with muscular dystrophy. Muscle Nerve. 2005;31:713–718.
  • Cup EH, Kinebanian A, Satink T, et al. Living with myotonic dystrophy; what can be learned from couples? A qualitative study. BMC Neurol. 2011;11:86.
  • LaDonna KA, Koopman WJ, Ray SL, et al. Hard to swallow: a phenomenological exploration of the experience of caring for individuals with myotonic dystrophy and dysphagia. J Neurosci Nurs. 2016;48:42–51.
  • Timman R, Tibben A, Wintzen AR. Myotonic dystrophy: the burden for patients and their partners. J Rehabil Med. 2010;42:823–830.
  • Knuijt S, Kalf JG, de Swart BJ, et al. Dysarthria and dysphagia are highly prevalent among various types of neuromuscular diseases. Disabil Rehabil. 2014;36:1285–1289.
  • Seijger CG, Drost G, Posma JM, et al. Overweight is an independent risk factor for reduced lung volumes in myotonic dystrophy type 1. PLoS One. 2016;11:e0152344.
  • Hilbert JE, Barohn RJ, Clemens PR, et al. 3rd and others. High frequency of gastrointestinal manifestations in myotonic dystrophy type 1 and type 2. Neurology. 2017;89:1348–1354.
  • Cruz Guzmán O. d R, Chávez García AL, Rodríguez-Cruz M. Muscular dystrophies at different ages: metabolic and endoncrine alterations. Int J Endocrinol. 2012; 2012:1.
  • Drewnowski A, Specter SE. Poverty and obesity: the role of energy density and energy costs. Am J Clin Nutr. 2004;79:6–16.
  • Gagnon C, Chouinard MC, Laberge L, et al. Prevalence of lifestyle risk factors in myotonic dystrophy type 1. Can J Neurol Sci. 2013;40:42–47.
  • Natterlund B, Sjoden PO, Ahlstrom G. The illness experience of adult persons with muscular dystrophy. Disabil Rehabil. 2001;23:788–798.
  • Meola G, Sansone V. Cerebral involvement in myotonic dystrophies. Muscle Nerve. 2007;36:294–306.
  • Van den Akker J, Gravemeiger K, McKenney S, et al. Introducing Educational Design Research. In: Van den Akker J, Gravemeiger K, McKenney S, Nieveen N, editors. Educational design research. London: Routledge; 2006.
  • Reeves TC. Design research from a technology perspective. In: Van den Akker J, editor. Design methodology and developmental research in education and training. The Netherlands: Kluwer; 2006. p. 52–66.
  • Saunders M, Lewis P, Thornhill A. Methoden en technieken van onderzoek. Amsterdam: Pearson Education Benelux; 2004.
  • Seesing FM, Groenewoud HJ, Drost G, et al. Cost-effectiveness of shared medical appointments for neuromuscular patients. Neurology. 2015;85:619–625.
  • Miller WR, Rollnick S. Motivational Interviewing: helping people change. New York: Guilford Press; 2012.
  • DiClemente CC, Prochaska JO. Toward a comprehensive, trans- theoretical model of change: Stages of change and addictive behaviors. In: Miller WR, Heather N, editors. Treating addictive behaviors. Volume 2nd. New York: Plenum Press; 1998. p. 3–24.
  • Lorig KR, Holman H. Self-management education: history, definition, outcomes, and mechanisms. Ann Behav Med. 2003;26:1–7.
  • van Staveren WA, de Boer JO, Burema J. Validity and reproducibility of a dietary history method estimating the usual food intake during one month. Am J Clin Nutr. 1985;42:554–559.
  • Vries J, de., Boer E, de., Hulshof K. Informatorium voor voeding en diëtetiek - voedingsleer. Houten: Bohn Stafleu van Loghum; 2013.
  • Chen AY, Frankowski R, Bishop-Leone J, et al. The development and validation of a dysphagia-specific quality-of-life questionnaire for patients with head and neck cancer: the M. D. Anderson dysphagia inventory. Arch Otolaryngol Head Neck Surg. 2001;127:870–876.
  • Speyer R, Heijnen BJ, Baijens LW, et al. Quality of life in oncological patients with oropharyngeal dysphagia: validity and reliability of the Dutch version of the MD Anderson Dysphagia Inventory and the Deglutition Handicap Index. Dysphagia. 2011;26:407–414.
  • Bogaardt HC, Speyer R, Baijens LW, et al. Cross-cultural adaptation and validation of the Dutch version of SWAL-QoL. Dysphagia. 2009;24:66–70.
  • Dedding C, Cardol M, Eyssen IC, et al. Validity of the Canadian Occupational Performance Measure: a client-centred outcome measurement. Clin Rehabil. 2004;18:660–667.
  • Health Council of the Netherlands. Dutch dietary guidelines. The Hague: Health Council of the Netherlands; 2016.
  • Bostrom K, Ahlstrom G. Quality of life in patients with muscular dystrophy and their next of kin. Int J Rehabil Res. 2005;28:103–109.
  • Bellini M, Biagi S, Stasi C, et al. Gastrointestinal manifestations in myotonic muscular dystrophy. WJG. 2006;12:1821.
  • LaDonna KA, Koopman WJ, Venance SL. Myotonic dystrophy (DM1) and dysphagia: the need for dysphagia management guidelines and an assessment tool. Can J Neurosci Nurs. 2011;33:42–46.
  • Prochaska JJ, Spring B, Nigg CR. Multiple health behavior change research: an introduction and overview. Prev Med. 2008;46:181–188.
  • Meola G, Sansone V, Perani D, et al. Executive dysfunction and avoidant personality trait in myotonic dystrophy type 1 (DM-1) and in proximal myotonic myopathy (PROMM/DM-2). Neuromuscul Disord. 2003;13:813–821.
  • Okkersen K, Buskes M, Groenewoud J, et al. The cognitive profile of myotonic dystrophy type 1: a systematic review and meta-analysis. Cortex. 2017;95:143–155.
  • Morrow S. Quality and trustworthiness in qualitative research in counseling psychology. J Counsel Psychol. 2005;52:250–260.
  • Geirdal AO, Lund-Petersen I, Heiberg A. Understanding the experience of myotonic dystrophy. Mixed method study. J Genet Counsel. 2015;24:169–178.